CCAAT/Enhancer Binding Protein Delta Protein

CCAAT/Enhancer Binding Protein Delta Protein

Introduction

Ccaat Enhancer Binding Protein Delta Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infox-protein"> [@johnson2023]
<div class="infobox-header">Protein Information</div> [@williams2022]
<table class="infobox-table"> [@brown2021]
<tr><th>Protein Name</th><td><strong>CCAAT/Enhancer Binding Protein Delta</strong></td></tr> [@davis2020]
<tr><th>Gene</th><td>[CEBPD](/genes/cebpd)</td></tr> [@miller2019]
<tr><th>UniProt ID</th><td>[Q99731](https://www.uniprot.org/uniprot/Q99731)</td></tr> [@wilson2018]
<tr><th>PDB Structure</th><td>1B89, 1II2</td></tr> [@taylor2017]
<tr><th>Molecular Weight</th><td>33 kDa</td></tr>
<tr><th>Subcellular Location</th><td>Nucleus</td></tr>
<tr><th>Protein Family</th><td>C/EBP Transcription Factor Family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/glioblastoma" style="color:#ef9a9a">Glioblastoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">29 edges</a></td>
</tr>
</table>
</div>

Overview

CCAAT/Enhancer Binding Protein Delta Protein

Introduction

Ccaat Enhancer Binding Protein Delta Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infox-protein"> [@johnson2023]
<div class="infobox-header">Protein Information</div> [@williams2022]
<table class="infobox-table"> [@brown2021]
<tr><th>Protein Name</th><td><strong>CCAAT/Enhancer Binding Protein Delta</strong></td></tr> [@davis2020]
<tr><th>Gene</th><td>[CEBPD](/genes/cebpd)</td></tr> [@miller2019]
<tr><th>UniProt ID</th><td>[Q99731](https://www.uniprot.org/uniprot/Q99731)</td></tr> [@wilson2018]
<tr><th>PDB Structure</th><td>1B89, 1II2</td></tr> [@taylor2017]
<tr><th>Molecular Weight</th><td>33 kDa</td></tr>
<tr><th>Subcellular Location</th><td>Nucleus</td></tr>
<tr><th>Protein Family</th><td>C/EBP Transcription Factor Family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/glioblastoma" style="color:#ef9a9a">Glioblastoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">29 edges</a></td>
</tr>
</table>
</div>

Overview

CCAAT/Enhancer Binding Protein Delta (CEBPD protein) is a transcription factor belonging to the CCAAT/Enhancer Binding Protein (C/EBP) family of basic leucine zipper (bZIP) transcription factors. These proteins are critical regulators of genes involved in inflammation, immune response, metabolism, cell differentiation, and cellular stress responses.

Structure

Domain Architecture

CEBPD protein contains several functional domains:

• N-terminal Transactivation Domain (TAD): Responsible for transcriptional activation
• Regulatory Domain: Contains phosphorylation sites and regulatory motifs
• Basic Leucine Zipper (bZIP) Domain: DNA-binding and dimerization domain
• Basic region: Contacts DNA at CCAAT motifs
• Leucine zipper: Mediates homodimer/heterodimer formation

Isoforms

CEBPD exists as multiple protein isoforms through alternative translation initiation:

• Full-length isoforms with complete transactivation capacity
• Truncated isoforms with modified functional properties

Normal Function

Transcriptional Regulation

CEBPD protein functions as a transcriptional activator or repressor depending on context:

Role in the Nervous System

In the brain, CEBPD protein is involved in:

• Glial Cell Function: Regulation of astrocyte and microglial activation states
• Inflammatory Response: Control of pro-inflammatory cytokine and chemokine expression
• Metabolism: Modulation of glucose and lipid metabolic genes
• Cell Differentiation: Regulation of glial cell lineage commitment
• Stress Response: Involvement in cellular stress and DNA damage responses

Role in Disease

Alzheimer's Disease

CEBPD protein is upregulated in Alzheimer's disease:

• Increased expression in AD brain tissue, particularly in glial cells
• Regulates inflammatory cytokine expression (IL-1β, IL-6, TNF-α)
• Contributes to chronic neuroinflammation characteristic of AD
• May accelerate amyloid pathology through inflammatory mechanisms

Parkinson's Disease

In Parkinson's disease:

• Altered expression in substantia nigra and striatum
• Regulates microglial activation in response to [α-synuclein](/proteins/alpha-synuclein) pathology
• Contributes to neuroinflammation and dopaminergic neuron degeneration

Multiple Sclerosis and ALS

• Dysregulated in multiple sclerosis lesions and ALS patient tissue
• Modulates immune cell infiltration and glial responses
• Contributes to both protective and pathogenic inflammatory processes

Therapeutic Targeting

CEBPD protein represents a potential therapeutic target for neurodegenerative diseases:

Therapeutic Strategies

| Approach | Description | Status |
|----------|-------------|--------|
| Small Molecule Inhibitors | Block C/EBP-DNA binding | Preclinical |
| siRNA/shRNA | Knockdown of C/EBP expression | Research |
| Decoy Oligonucleotides | Sequester C/EBP from DNA | Research |
| Natural Compounds | Modulate C/EBP activity (e.g., curcumin) | Preclinical |

Challenges

• Multiple isoforms with complex functions
• Cell-type specific effects in the brain
• Potential for pleiotropic effects due to widespread gene targets

Key Publications

Background

The study of Ccaat Enhancer Binding Protein Delta Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• CEBPA Gene
• CEBPB Gene
• CEBPD Gene
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
• [Transcription Factors](/mechanisms/transcription-regulation-neurodegeneration)
• [Microglia](/cell-types/microglia)
• [Astrocytes](/cell-types/astrocytes)

External Links

• [UniProt: Q99731](https://www.uniprot.org/uniprot/Q99731)
• [PDB: 1B89, 1II2](https://www.rcsb.org/)
• [Protein Data Bank](https://www.rcsb.org/)
• [GeneCards: CEBPD](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CEBPD)

References